German Hodgkin Study Group
For over 30 years now, the German Hodgkin Study Group (GHSG) has been committed to optimizing diagnostics, therapy and follow-up care in Hodgkin lymphoma, and so far over 15,000 patients have participated in its trials.
The GHSG’s Trial Coordination Center belongs to the Department I of Internal Medicine of the University of Cologne. It recruits patients from all across Europe to include them in its clinical trials. With the results of its various large-scale trials (controlled, prospective, randomized trials) for all stages of Hodgkin lymphoma, the GHSG has contributed decisively to the great progress that has been made in Hodgkin lymphoma therapy over the years. Based on these results, the GHSG’s latest trials are aimed to reduce adverse effects of therapy while maintaining cure rates.
On this website we offer information on Hodgkin lymphoma, current therapies and the activities of the GHSG.
It is designed for physicians, patients and anyone who might be interested.
Should you not find the information you’ve been looking for, please don’t hesitate to contact us.
If you would like to support our work, please click here for more information.